Time |
Topic |
Speaker |
09:00-09:10
|
Welcome Remarks |
회장 김성용 (순천향의대)
|
09:10-10:35
|
Session I : Hormone Receptor Positive and HER2 Negative Breast Cancer |
좌장: 한원식 (서울의대) |
09:10-09:35
|
Adding targeted therapy including IO for high-risk early HR+ breast cancer |
배숭준 (연세의대) |
09:35-10:00
|
Targeting PIK3CA-AKT-mTOR in luminal breast cancer
|
이수정 (경북의대) |
10:00-10:25
|
Treatment of metastatic luminal breast cancer after endocrine treatment failure |
이대원 (서울의대) |
10:25-10:35
|
Discussion |
- |
10:35-10:50
|
Coffee Break
|
10:50-12:15
|
Session II : HER2 Positive Breast Cancer |
좌장: 손주혁 (연세의대) |
10:50-11:15
|
Updates of systemic treatments in HER2+ early breast cancer |
김희준 (중앙의대) |
11:15-11:40
|
ADC and new TKI in HER2+ MBC |
김주원 (고려의대) |
11:40-12:05
|
De-escalating chemo in HER2+ BC |
박민호 (전남의대) |
12:05-12:15
|
Discussion |
- |
12:15-13:20
|
Lunch |
13:20-14:45
|
Session III : Triple Negative Breast Cancer
|
좌장: 박경화 (고려의대) |
13:20-13:45
|
Targeting BRCA mutation and HRD |
김민환 (연세의대) |
13:45-14:10
|
Escalation or De-escalation strategy in early TNBC |
윤창익 (가톨릭의대) |
14:10-14:35
|
Emerging ADC and targeted treatment in metastatic TNBC |
김한조 (순천향의대) |
14:35-14:45
|
Discussion |
- |
14:45-15:00
|
Coffee Break |
15:00-16:25
|
Session IV : Treatment Strategies for Special Population
|
좌장: 정준 (연세의대) |
15:00-15:25
|
Systemic treatment after loco-regional recurrence |
김민균 (중앙의대) |
15:25-15:50
|
Best systemic treatment for fertility preservation in young breast cancer |
김희정 (울산의대) |
15:50-16:15
|
Treatment of Rare histology in breast cancer |
정성의 (고신의대) |
16:15-16:25
|
Discussion |
- |
16:25-16:35
|
Closing Remarks |
이사장 한원식 (서울의대) |